TITLE

Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review

AUTHOR(S)
Watanabe, Norio; Churchill, Rachel; Furukawa, Toshi A.
PUB. DATE
January 2007
SOURCE
BMC Psychiatry;2007, Vol. 7, p18
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The efficacy of combined psychotherapy and benzodiazepine treatment for panic disorder is still unclear despite its widespread use. The present systematic review aims to examine its efficacy compared with either monotherapy alone. Methods: All randomised trials comparing combined psychotherapy and benzodiazepine for panic disorder with either therapy alone were identified by comprehensive electronic search on the Cochrane Registers, by checking references of relevant studies and of other reviews, and by contacting experts in the field. Two reviewers independently checked eligibility of trials, assessed quality of trials and extracted data from eligible trials using a standardized data extraction form. Our primary outcome was "response" defined by global judgement. Authors of the original trials were contacted for further unpublished data. Meta-analyses were undertaken synthesizing data from all relevant trials. Results: Only two studies, which compared the combination with behaviour (exposure) therapy, met our eligibility criteria. Both studies had a 16-week intervention. Unpublished data were retrieved for one study. The relative risk for response for the combination was 1.25 (95%CI: 0.78 to 2.03) during acute phase treatment, 0.78 (0.45 to 1.35) at the end of treatment, and 0.62 (0.36 to 1.07) at 6-12 months follow-up. Some secondary outcomes hinted at superiority of the combination during acute phase treatment. One study was identified comparing the combination to benzodiazepine. The relative risk for response was 1.57 (0.83 to 2.98), 3.39 (1.03 to 11.21, statistically significant) and 2.31 (0.79 to 6.74) respectively. The superiority of the combination was observed on secondary outcomes at all the time points. No subgroup analyses were conducted due to the limited number of included trials. Conclusion: Unlike some narrative reviews in the literature, our systematic search established the paucity of high quality evidence for or against the combined psychotherapy plus benzodiazepine therapy for panic disorder. Based on limited available published and unpublished data, however, the combined therapy is probably to be recommended over benzodiazepine alone for panic disorder with agoraphobia. The combination might be superior to behaviour therapy alone during the acute phase, but afterwards this trend may be reversed. We know little from these trials about their adverse effects.
ACCESSION #
29962935

 

Related Articles

  • Agoraphobia: The Long-Term Follow-up of Behavioural Treatment. Munby, Mary; Johnston, Derek W. // British Journal of Psychiatry;Nov80, Vol. 137, p418 

    Sixty-six agoraphobic patients were followed up five to nine years after their treatment in three clinical trials of behaviour therapy. The main outcome measures used in the original trials were repeated by an assessor who interviewed the patients. Ninety-five per cent of patients were...

  • Effectiveness of cognitive-behavioral group therapy for panic disorder in a specialized unit. Prats, Eva; Domínguez, Elisabet; Rosado, Silvia; Pailhez, Guillem; Bulbena, Antoni; Fullana, Miquel A. // Actas Espanolas de Psiquiatria;jul/ago2014, Vol. 42 Issue 4, p176 

    Introduction. The efficacy of cognitive-behavior therapy for panic disorder (PD) with or without agoraphobia is well established, but few data exist on its effectiveness using a group format. The goal of the present study was to assess the effectiveness of group CBT in a sample of PD patients in...

  • Panic disorder: Guidelines to safe use of benzodiazepines. Garvey, Michael J. // Geriatrics;Jul93, Vol. 48 Issue 7, p49 

    Features therapeutic guidelines for the safe use of benzodiazepines for panic-disorder cases. Etiology of disease; Diagnosis of four key elements; Selection from drug classes of treatment; Allaying patient fears with regards to substance dependence. INSET: Treatment of panic disorders..., by...

  • Alprazolam.  // AHFS Consumer Medication Information;Jul2016, p1 

    Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.

  • A Comparison of Subliminal, Supraliminal and Faded Phobic Cine-Films in the Treatment of Agoraphobia. Lee, Ian; Tyrer, Peter; Horn, Sandra // British Journal of Psychiatry;Oct83, Vol. 143, p356 

    Thirty-two agoraphobic patients were randomly allocated to four groups and treated by repeated exposure to cine-films at twice weekly intervals for three weeks. Three of the groups saw the same cine-film, comprising a range of agoraphobic scenes, and a control group saw a potter working on his...

  • Acceptance and Commitment Therapy (ACT) in the Treatment of Panic Disorder: Some Considerations from the Research on Basic Processes. Carrascoso L�pez, Francisco Javier; Salas, Sonsoles Valdivia // International Journal of Psychology & Psychological Therapy;2009, Vol. 9 Issue 3, p299 

    The prevalence of panic disorder with and without agoraphobia as well as its personal and economic impact is encouraging researchers and clinicians to improve the available psychological treatments. Cognitive-behavioral therapy for panic disorder has yielded large size effects, still the...

  • Long-Term Effects of Behavioural Treatment for Panic Disorder with Agoraphobia. Fava, Giovanni A.; Zielezny, Maria; Savron, Gianni; Grandi, Silvana // British Journal of Psychiatry;Jan95, Vol. 166, p87 

    Background. There are few long-term follow-up studies of panic disorder treatments, particularly when patients have been treated by behavioural methods only and have recovered. Method. 110 consecutive patients satisfying the DSM-III-R criteria for panic disorder with agoraphobia were treated in...

  • Treatment Modality Preferences and Adherence to Group Treatment for Panic Disorder with Agoraphobia. Perreault, Michel; Julien, Dominic; White, Noé; Bélanger, Claude; Marchand, André; Katerelos, Theodora; Milton, Diana // Psychiatric Quarterly;Jun2014, Vol. 85 Issue 2, p121 

    To examine the relationship between preference for group psychotherapy and adherence to group cognitive-behavioral therapy (CBT) for clients with panic disorder with agoraphobia (PDA), 109 participants experiencing PDA completed a questionnaire measuring preference for group treatment (PGTQ)...

  • L'identification et traitement du trouble panique avec ou sans agoraphobie. Foldes-Busque, Guillaume; Marchand, André; Landry, Pierre // Canadian Family Physician;Oct2007, Vol. 53, p1686 

    OBJECTIVE To describe for family physicians screening, diagnosis, and treatment of panic disorder with or without agoraphobia (PD/A). QUALITY OF EVIDENCE Articles were identified through PsycLIT, PsyINFO, and MEDLINE (1985 to 2006) using the terms panic disorder, psychotherapy, psychosocial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics